At UC, 70% of undergrads participate in research, creative projects or service learning. Three new programs bridge classroom ...
First patient dosed in Opti-GAIN, a first-in-human Phase I/II clinical trial of CTx001 in Geographic Atrophy secondary to AMD CTx001 is an investigational AAV-based gene therapy designed to deliver ...
A first-in-human clinical trial evaluating an investigational gene therapy targeting complement-mediated pathways in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results